Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Indivior Plc ADR (OP: INVVY ) N/A UNCHANGED Last Price Updated: 10:23 AM EDT, Jun 9, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Indivior Plc ADR Indivior Reaches $102.5M Settlement To Resolve Antitrust Litigation June 05, 2023 Indivior PLC (OTCPK:INVVY) (OTCPK:IZQVF) (LSE: NDV), an addiction treatment company, announced that its subsidiary, Indivior Inc., has reached an agreement to resolve the claims brought by the... Via Benzinga Activist Investor Recommends Yelp Explore Sale, Micron Projects China Ban To Curb Revenues, Spruce Point Capital Raises Concerns About Perion Network's Financial Practices: Today's Top News May 23, 2023 Wall Street Journal Via Benzinga Nasal-Spray Millionaire: Indivior's Opvee Nasal Spray Gets FDA Green Light for Opioid Overdose Treatment May 23, 2023 The FDA has approved Indivior PLC's (OTC: INVVY) Opvee (nalmefene) nasal spray for the emergency treatment of opioid overdose in adults and pediatric patients aged 12 years and older. Via Benzinga Indivior Acquires Opiant Pharmaceuticals Strengthening Its Addiction Treatment And Science Portfolio March 03, 2023 Indivior PLC (OTCPK:INVVY) (LSE:INDV) has completed the acquisition of Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) The transaction strengthens Indivior's addiction treatment and science portfolio by... Via Benzinga Indivior Targeting Listing On NASDAQ For The Spring Of 2023 December 07, 2022 Indivior PLC (OTCPK:INVVY) (LON:INDV) will hold a capital markets day on December 7th in New York City. The event will be hosted by Mark Crossley, CEO, along with members of the Indivior executive... Via Benzinga Facebook Stalls Portal & Smartwatch Projects, Visa Breaks Debit Card Tie Up With FTX, $3B Bitcoin Withdrawn From Crypto Exchanges: Top Stories Monday, Nov. 14 November 14, 2022 Reuters Via Benzinga Indivior To Pay Over 100% Premium To Buy Opioid Focused Player Opiant Pharmaceuticals November 14, 2022 Via Benzinga Hypocrisy All Around: Pfizer, NFL Are Hidden Sponsors Of Anti-Drug Group Fighting Against Cannabis Legalization August 17, 2022 The Community Anti-Drug Coalitions of America (CADCA), which is fighting against federal cannabis legalization, recently removed a page on its website disclosing its partners. Via Benzinga Indivior Positioned To Profit If Aelis Farma's Study Of Cannabis Use Disorder Succeeds June 01, 2022 Indivior PLC (OTCPK:INVVY) (LON:INDV) announces the enrollment of the first patient in the Phase 2b study of AEF0117 for the treatment of cannabis use disorder (CUD). Via Benzinga Indivior Study Shows Buprenorphine May Mitigate Fentanyl-Induced Respiratory Depression In Chronic Opioid Users April 11, 2022 Indivior PLC (OTCPK:INVVY) (LON:INDV) published modeling data examining the competitive interaction between buprenorphine, a treatment for opioid use disorder, and fentanyl, a potent synthetic opioid,... Via Benzinga Cannabis Movers & Shakers: MedMen, IM Cannabis, Avicanna, Avant Brands January 13, 2022 MedMen's CRO Tracy McCourt Named President Of Emerald Village West Hollywood Cannabis retailer MedMen Enterprises Inc. Via Benzinga Using Opioid Addiction Drug Buprenorphine May Cause Dental Issues, FDA Flags January 13, 2022 The FDA warned patients and prescribers about the risk of potential dental problems arising from the use of buprenorphine medicines to treat opioid addiction and pain.... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.